239 related articles for article (PubMed ID: 30353687)
41. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
[TBL] [Abstract][Full Text] [Related]
43. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
44. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
Liu K; Kang M; Liao X; Wang R
PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040
[TBL] [Abstract][Full Text] [Related]
45. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
46. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of
Wang D; Jia Y; Zheng W; Li C; Cui W
Dis Markers; 2019; 2019():6019637. PubMed ID: 31885740
[TBL] [Abstract][Full Text] [Related]
48. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
49. DNA methylation biomarkers for lung cancer.
Rauch TA; Wang Z; Wu X; Kernstine KH; Riggs AD; Pfeifer GP
Tumour Biol; 2012 Apr; 33(2):287-96. PubMed ID: 22143938
[TBL] [Abstract][Full Text] [Related]
50. Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.
Lv Z; Lei T
BMC Cancer; 2020 Jan; 20(1):56. PubMed ID: 31987030
[TBL] [Abstract][Full Text] [Related]
51. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
[TBL] [Abstract][Full Text] [Related]
52. High
Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629
[TBL] [Abstract][Full Text] [Related]
53. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
54. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
56. DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma.
Xu D; Li C; Zhang Y; Zhang J
BMC Pulm Med; 2022 Apr; 22(1):133. PubMed ID: 35392867
[TBL] [Abstract][Full Text] [Related]
57. Methylation biomarkers with discriminating ability are potential therapeutic targets in lung adenocarcinoma.
Zhao W; Rong Z; Wang W; Li S; Lu Y; Cao L; Zhang L; Yang K; Deng K; Yang C; Li K
Epigenomics; 2022 Apr; 14(8):469-480. PubMed ID: 33290106
[No Abstract] [Full Text] [Related]
58. Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma.
Hua Y; Ma X; Liu X; Yuan X; Qin H; Zhang X
PLoS One; 2017; 12(3):e0174461. PubMed ID: 28350845
[TBL] [Abstract][Full Text] [Related]
59. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA.
Wang K; Liu Y; Lu G; Xiao J; Huang J; Lei L; Peng J; Li Y; Wei S
Cancer Med; 2022 Jan; 11(1):281-294. PubMed ID: 34854250
[TBL] [Abstract][Full Text] [Related]
60. Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis.
Wang J; Chen T; Yu X; OUYang N; Tan L; Jia B; Tong J; Li J
J Transl Med; 2020 Aug; 18(1):313. PubMed ID: 32795291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
